VasoDynamics files global patent (PCT) for the methods to select patients for the clinical studies on radiation-induced oral mucositis Gallery VasoDynamics files global patent (PCT) for the methods to select patients for the clinical studies on radiation-induced oral mucositis By Chloe Atkinson|2025-05-20T09:41:00+00:00November 7th, 2023|News| Read More
NG11-2 Phase Ib Dose Escalation Clinical Study Progressing through Dose Levels Gallery NG11-2 Phase Ib Dose Escalation Clinical Study Progressing through Dose Levels By Chloe Atkinson|2025-05-20T09:39:47+00:00October 16th, 2023|Clinical Development, News, NG11| Read More
VasoDynamics strengthens management team with key appointments Gallery VasoDynamics strengthens management team with key appointments By Chloe Atkinson|2025-02-17T12:37:11+00:00August 1st, 2023|Corporate Development, News| Read More
First dose cohort completed and enrolment to second dose cohort commenced in NG11-2 Phase-Ib clinical trial Gallery First dose cohort completed and enrolment to second dose cohort commenced in NG11-2 Phase-Ib clinical trial By Chloe Atkinson|2025-05-20T09:40:01+00:00July 28th, 2023|Clinical Development, News, NG11| Read More
First patient dosed for the first week in NG11-2 Phase Ib clinical trial Gallery First patient dosed for the first week in NG11-2 Phase Ib clinical trial By Chloe Atkinson|2025-02-17T11:59:27+00:00May 26th, 2023|Clinical Development, News, NG11| Read More
First patient enrolled in NG11-2 Phase Ib clinical trial Gallery First patient enrolled in NG11-2 Phase Ib clinical trial By Chloe Atkinson|2025-05-20T09:39:27+00:00May 8th, 2023|Clinical Development, News, NG11| Read More
VasoDynamics Receives Global Health and Pharma Biotechnology 2023 Award Gallery VasoDynamics Receives Global Health and Pharma Biotechnology 2023 Award By Chloe Atkinson|2025-02-17T12:47:05+00:00April 12th, 2023|News| Read More
VasoDynamics Receives UK MHRA-REC Approval On NG11-2 Phase Ib Clinical Trial Gallery VasoDynamics Receives UK MHRA-REC Approval On NG11-2 Phase Ib Clinical Trial By Chloe Atkinson|2025-05-20T09:39:11+00:00January 24th, 2023|Clinical Development, News, NG11| Read More
VasoDynamics files UK patent for Radiotherapy-Induced Oral Mucositis (RIOM) Clinical Trial Methodology Gallery VasoDynamics files UK patent for Radiotherapy-Induced Oral Mucositis (RIOM) Clinical Trial Methodology By Chloe Atkinson|2025-05-20T09:36:31+00:00December 22nd, 2022|Clinical Development, News| Read More
VasoDynamics submits UK Clinical Trial Application for NG11-2 Gallery VasoDynamics submits UK Clinical Trial Application for NG11-2 By Chloe Atkinson|2025-05-20T09:38:29+00:00October 21st, 2022|Clinical Development, News, NG11| Read More
